The Ophthalmological Complications of Targeted Agents in Cancer Therapy: What Do We Need to Know as Ophthalmologists?

    September 2012 in “ Acta ophthalmologica ”
    Wing Lau Ho, Hiu Yung Wong, Thomas Yau
    Studysummary This review highlights that various targeted cancer therapies are associated with specific ocular side-effects, emphasizing the importance of awareness among ophthalmologists for timely diagnosis and management.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Cetuximab-Induced Hypertrichosis of the Scalp and Eyelashes Journal of The American Academy of Dermatology · 2010